Author

Michael Thormann

ORCID 0009-0001-3826-5851Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:deep learning· 1 Research Focus:drug response / drug discovery· 1 Approach:statistical model· 1 Organism:Xenopus· 1

Frequent Co-Authors

Gergana Galabova· 1 shared Nadine Traube· 1 shared Nanna MacAulayiD· 1 shared Nasser Yehia· 1 shared Roland Koestler· 1 shared Trine Lisberg Toft‐BertelseniD· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

6 top collaborators · 15 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPharmacology & Toxicology

Gergana Galabova

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Pharmacology & ToxicologyInternational Journal of Molecular SciencesPeer-reviewedJan 11, 2024

Towards new AQP4 inhibitors: ORI-TRN-002

Michael Thormann, Nadine Traube, Nasser Yehia…·Trine Lisberg Toft‐Bertelsen

This paper identifies ORI-TRN-002 as a novel AQP4 inhibitor with improved solubility and low protein binding, potentially useful for antiedema therapy.

5 citations

Xenopusdeep learning

𝕏 PostBluesky